What this study is
Myoinositol is an insulin-like compound that is present in both plant and animal cells. Humans synthesize it naturally, but it is also obtained in our diet. It works through an intracellular signaling pathway to increase insulin sensitivity. Myoinositol has been used as an over-the-counter (OTC) supplement in the management of polycystic ovarian syndrome due to this effect. Myoinositol has also been shown to improve glycemic profiles in pregnant euglycemic women and well as improve insulin sensitivity in pregnant patients with gestational diabetes mellitus (GDM).
This is a double blind RCT offering myo-inositol or placebo to those who are eligible and enrolled.
What's being tested
- Myo-inositol
Intervention · DIETARY SUPPLEMENT
Patients would begin taking myoinositol upon recruitment
- Myo-inositol placebo
Intervention · DIETARY SUPPLEMENT
Patients would begin taking placebo upon recruitment
Study details
- Official title
- Continuous Glucose Monitoring in Myo-inositol Supplemented Obese Pregnant Individuals: a Feasibility Pilot Randomized Control Trial
- Sponsor
- Tufts Medical Center
- Conditions
- Pregnancy Related
- Enrolling
- 40 people
- Starts
- 2025-03-01
- Est. completion
- 2027-06-30
- Design
- Triple-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 45 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Singleton gestations
- Women aged > 18 years and < 45 years
- Recruited before 16 weeks gestation
- Obese (pre-pregnancy BMI ≥ 30)
- Receiving prenatal care at Tufts Medical Center
- Planning to give birth at Tufts Medical Center
- Can tolerate glucose tolerance test
- Willing and able to wear CGM
- Willing and able to sign informed consent
You can't join if
- Multiple gestation
- Preexisting diabetes
- Taking medications that impact body weight or metabolism (eg metformin)
- Inability to tolerate glucose tolerance test
- Adults unable to consent (cognitively impaired adults)
- Wards of the state
- Non-viable neonates
- Neonates of uncertain viability
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openTufts Medical Center
Boston, Massachusetts, United States
- Zeunab Kassem · Contact617-636-9897zeinab.kassem@tuftsmedicalcenter.org
Recruiting
Study team
Sponsor
Tufts Medical Center
Study ID STUDY00005304
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.